Literature DB >> 11447299

Endothelin receptor antagonist.

M Clozel.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11447299     DOI: 10.1023/a:1011460318319

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


× No keyword cloud information.
  11 in total

1.  Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension.

Authors:  Y Matsumura; T Kuro; Y Kobayashi; F Konishi; M Takaoka; J L Wessale; T J Opgenorth; C E Gariepy; M Yanagisawa
Journal:  Circulation       Date:  2000-11-28       Impact factor: 29.690

2.  Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.

Authors:  P Mulder; V Richard; G Derumeaux; M Hogie; J P Henry; F Lallemand; P Compagnon; B Macé; E Comoy; B Letac; C Thuillez
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

4.  Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction.

Authors:  K Hu; P Gaudron; T J Schmidt; K D Hoffmann; G Ertl
Journal:  J Cardiovasc Pharmacol       Date:  1998-09       Impact factor: 3.105

5.  Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: evidence for an endothelin-mediated mechanism.

Authors:  J J Boffa; P L Tharaux; S Placier; R Ardaillou; J C Dussaule; C Chatziantoniou
Journal:  Circulation       Date:  1999-11-02       Impact factor: 29.690

6.  Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.

Authors:  D Fraccarollo; K Hu; P Galuppo; P Gaudron; G Ertl
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

7.  LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction.

Authors:  Q T Nguyen; F Colombo; J L Rouleau; J Dupuis; A Calderone
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

8.  ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats.

Authors:  E Oie; R Bjønerheim; H K Grogaard; H Kongshaug; O A Smiseth; H Attramadal
Journal:  Am J Physiol       Date:  1998-09

9.  Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat.

Authors:  Q T Nguyen; P Cernacek; A Calderoni; D J Stewart; P Picard; P Sirois; M White; J L Rouleau
Journal:  Circulation       Date:  1998-11-24       Impact factor: 29.690

10.  Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.

Authors:  Y Iwanaga; Y Kihara; K Hasegawa; K Inagaki; T Yoneda; S Kaburagi; M Araki; S Sasayama
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

View more
  1 in total

1.  Pulmonary vasoconstrictor influence of endothelin in exercising swine depends critically on phosphodiesterase 5 activity.

Authors:  Zhichao Zhou; Vincent J de Beer; Daphne de Wijs-Meijler; Shawn B Bender; Maaike Hoekstra; M Harold Laughlin; Dirk J Duncker; Daphne Merkus
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-10       Impact factor: 5.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.